Takeda Pharmaceutical Co Ltd (TAK)
13.62
+0.06
(+0.41%)
USD |
NYSE |
Nov 15, 16:00
13.62
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly): 53.58B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 53.58B |
| June 30, 2024 | 52.37B |
| March 31, 2024 | 51.76B |
| December 31, 2023 | 53.04B |
| September 30, 2023 | 52.22B |
| June 30, 2023 | 54.36B |
| March 31, 2023 | 57.06B |
| December 31, 2022 | 55.89B |
| September 30, 2022 | 54.51B |
| June 30, 2022 | 56.72B |
| March 31, 2022 | 61.40B |
| December 31, 2021 | 64.02B |
| September 30, 2021 | 64.64B |
| June 30, 2021 | 67.11B |
| March 31, 2021 | 70.12B |
| December 31, 2020 | 74.14B |
| September 30, 2020 | 73.32B |
| June 30, 2020 | 73.64B |
| March 31, 2020 | 74.89B |
| December 31, 2019 | 74.89B |
| September 30, 2019 | 74.20B |
| June 30, 2019 | 80.41B |
| March 31, 2019 | 77.62B |
| December 31, 2018 | 33.75B |
| September 30, 2018 | 18.50B |
| Date | Value |
|---|---|
| June 30, 2018 | 18.94B |
| March 31, 2018 | 19.66B |
| December 31, 2017 | 20.19B |
| September 30, 2017 | 20.18B |
| June 30, 2017 | 20.61B |
| March 31, 2017 | 21.45B |
| December 31, 2016 | 18.04B |
| September 30, 2016 | 19.00B |
| June 30, 2016 | 18.95B |
| March 31, 2016 | 16.13B |
| December 31, 2015 | 16.83B |
| September 30, 2015 | 16.94B |
| June 30, 2015 | 17.03B |
| March 31, 2015 | 17.41B |
| December 31, 2014 | 17.41B |
| September 30, 2014 | 18.65B |
| June 30, 2014 | 19.56B |
| March 31, 2014 | 19.71B |
| December 31, 2013 | 18.80B |
| September 30, 2013 | 19.48B |
| June 30, 2013 | 16.83B |
| March 31, 2013 | 18.21B |
| December 31, 2012 | 19.32B |
| September 30, 2012 | 19.46B |
| June 30, 2012 | 19.12B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
51.76B
Minimum
Mar 2024
74.89B
Maximum
Mar 2020
61.98B
Average
59.23B
Median
Total Liabilities (Quarterly) Benchmarks
| HUTCHMED (China) Ltd | 508.85M |
| Astellas Pharma Inc | 13.04B |
| Nxera Pharma Co Ltd | 543.75M |
| PeptiDream Inc | 230.61M |
| Healios KK | 90.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.04B |
| Shareholders Equity (Quarterly) | 48.46B |
| Debt to Equity Ratio | 0.7299 |
| Current Ratio | 1.279 |
| Net Debt Paydown Yield | -1.15% |